Cipla
Break Gilead’s patent since US has bought all stock of Remdesivir

Trump is trying to improve his waning electoral chances by reserving all of Gilead’s stock of Remdesivir to cover up his disastrous handling of the Covid-19 epidemic so far

US Buys Up Remdesivir: We Must Break Patents for Access to COVID-19 Drug

Newsclick’s Prabir Purkayastha discusses the US buying out supplies of the COVID-19 drug, Remdesivir.

    × To Subscribe